IOBT Stock Risk & Deep Value Analysis

IO Biotech Inc

Healthcare • Biotechnology

DVR Score

0.1

out of 10

Distressed

The Bottom Line on IOBT

We analyzed IO Biotech Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran IOBT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Apr 14, 2026•Run Fresh Analysis →•

Get notified when IOBT moves

Same alert types as Telegram — presets or custom thresholds in your 🔔 feed.

📈IOBT Performance Overview3yr weekly

📊

Unlock IOBT Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

IOBT Quality Rating

0.0

Growth

0.0

Profitability

0.0

Health

0.0

Capital allocation

0.0

Momentum

IOBT Stock Risk Analysis

Overall Risk

Aggressive

Financial Risk

High

Market Risk

High

About IO Biotech Inc (IOBT)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$3.45M

IOBT Deep Value Analysis

IO Biotech Inc (IOBTQ) has filed for Chapter 7 bankruptcy liquidation as of March 31, 2026, leading to a complete shutdown of operations and termination of all employees. This catastrophic event eliminates any future growth potential or financial viability. Common stockholders are explicitly stated to be 'unlikely to receive any distribution.' The previous analysis acknowledged significant financial fragility and the binary nature of drug development, but the ultimate negative outcome has materialized. Consequently, there is no investment potential, and the risk of total loss is now virtually guaranteed for current shareholders, rendering the company a 'dud' by all metrics. The score reflects this complete lack of future value.

IOBT Research Sources

Research sources

No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.

For educational context only. Not financial advice.

IOBT Red Flags & Warning Signs

⚠
Finalization of Chapter 7 liquidation process
⚠
Official delisting from OTC markets

Unlock IOBT Red Flags & Risk Warnings

Premium members see every risk event we found.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

IOBT Financial Health Metrics

Market Cap

$3.45M

P/E Ratio

-0.04

Debt-to-Equity

42.86

Beta (Volatility)

0.66

Earnings Per Share

$-1.34

IOBT Competitive Moat Analysis

Moat Rating

None

Moat Trend

Eroding

The company's intellectual property and platform failed to translate into a viable product and ultimately led to bankruptcy, demonstrating a complete lack of durable moat.

IOBT Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

IOBT Catalysts & Growth Drivers

Near-Term (0-6 months)

•No positive catalysts; ongoing Chapter 7 liquidation process (0-6 months)

Medium-Term (6-18 months)

•No positive catalysts; asset sale and creditor distribution (6-18 months)

Long-Term (18+ months)

•No positive catalysts; permanent dissolution of the company (18+ months)

Catalysts & Growth Drivers

IOBT Bull Case: What Could Go Right

✓
None relevant for investment purposes; monitoring of bankruptcy proceedings will confirm the complete loss of shareholder value.
✓
Confirmation of asset distribution details from the bankruptcy court.

Bull Case Analysis

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for IO Biotech Inc (IOBT)?

As of April 14, 2026, IO Biotech Inc has a DVR Score of 0.1 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of IO Biotech Inc?

IO Biotech Inc's market capitalization is approximately $3.5M. The company operates in the Healthcare sector within the Biotechnology industry.

What ticker symbol does IO Biotech Inc use?

IOBT is the ticker symbol for IO Biotech Inc. The company trades on the NMS.

What is the risk level for IOBT stock?

Our analysis rates IO Biotech Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of IOBT?

IO Biotech Inc currently has a price-to-earnings (P/E) ratio of -0.0. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

How often is the IOBT DVR analysis updated?

Our AI-powered analysis of IO Biotech Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 14, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.